NGD vs. FSPHX

Last updated Jun 9, 2026

NGD (New Gold Inc.) is a stock, while FSPHX (Fidelity® Select Health Care Portfolio) is Health & Biotech Equities fund actively managed by Fidelity. At a 0.15 correlation, their price movements are largely independent.

Performance

NGD vs. FSPHX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in New Gold Inc. (NGD) and Fidelity® Select Health Care Portfolio (FSPHX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

NGD

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

FSPHX

• 1D: -1.54%
• 1M: 1.59%
• YTD: -3.55%
• 6M: -11.00%
• 1Y: 7.49%
• 3Y*: 3.79%
• 5Y*: 1.43%
• 10Y*: 8.63%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NGD vs. FSPHX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NGD New Gold Inc.	4.25%	251.21%	69.86%	48.98%	-34.67%	-31.51%	148.86%	16.28%	-77.00%	-6.00%
FSPHX Fidelity® Select Health Care Portfolio	-3.55%	9.36%	4.91%	4.13%	-12.82%	11.58%	24.57%	31.48%	7.15%	23.83%

Correlation

The correlation between NGD and FSPHX is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.15
Correlation (3Y) Calculated over the trailing 3-year period	0.19
Correlation (5Y) Calculated over the trailing 5-year period	0.22
Correlation (10Y) Calculated over the trailing 10-year period	0.14
Correlation (All Time) Calculated using the full available price history since Nov 19, 2004	0.15

Return for Risk

NGD vs. FSPHX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FSPHX

FSPHX Risk / Return Rank: 6
FSPHX Sharpe Ratio Rank: 7
FSPHX Sortino Ratio Rank: 6
FSPHX Omega Ratio Rank: 7
FSPHX Calmar Ratio Rank: 6
FSPHX Martin Ratio Rank: 5

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NGD vs. FSPHX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for New Gold Inc. (NGD) and Fidelity® Select Health Care Portfolio (FSPHX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	NGD	FSPHX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.48	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.08	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.45	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.75	—

Drawdowns

Drawdown Indicators

	NGD	FSPHX	Difference
Max Drawdown Largest peak-to-trough decline	—	-44.45%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-18.32%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-18.32%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-29.31%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-29.31%	—
Current Drawdown Current decline from peak	—	-12.78%	—
Average Drawdown Average peak-to-trough decline	—	-9.83%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	8.32%	—

Volatility

Volatility by Period

	NGD	FSPHX	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	5.92%	—
Volatility (6M) Calculated over the trailing 6-month period	—	14.68%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	17.90%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	18.37%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	19.04%	—

Dividends

NGD vs. FSPHX - Dividend Comparison

NGD has not paid dividends to shareholders, while FSPHX's dividend yield for the trailing twelve months is around 12.63%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FSPHX Fidelity® Select Health Care Portfolio	12.63%	4.16%	10.77%	0.00%	2.13%	9.06%	11.29%	1.35%	9.02%	2.27%	0.18%	11.63%
NGD New Gold Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both NGD and FSPHX in my portfolio?

NGD and FSPHX have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.